Your Article Summary
See Latest ArticlesRisk factors for inhibitor formation in haemophilia: a prevalent case–control study
Haemophilia, 07/01/09
Ragni MV et al. - Inhibitor formation is associated with high intensity product exposure, CNS bleeding, African-American race and low frequency of missense mutations. The ideal time to initiate prophylaxis to reduce CNS bleeding and inhibitor formation will require prospective studies.
Margaret V. Ragni, 06/30/09
| Hemophilia inhibitor formation is increasingly recognized to be related to early high dose bolus factor treatment, a potent antigenic challenge in very young infants. Because these inhibitors are associated with CNS bleeds, high burden of disease, poor outcomes, and early mortality, prevention is the key. Gene transfer studies in hemophilia mice and dogs suggests that low-level continuous factor VIII or IX may avert inhibitor formation. Whether continuous low level factor VIII or IX in such patients will prevent new inhibitor formation is a critical question, and wil require randomized clinical trials. |
Related Articles
Malignancy in patients with haemophilia: a review of the literature
Haemophilia, 11/16/09
Relevance Score: 89%
Upper gastrointestinal bleeding in children with haemophilia: a clinical significance of Helicobacter pylori infection
Haemophilia, 11/09/09
Relevance Score: 85%
Mosaicism and haemophilia
Haemophilia, 11/05/09
Relevance Score: 85%
Physical activity levels and participation in sport in Irish people with haemophilia
Haemophilia, 11/04/09
Relevance Score: 85%
Effectiveness of a balance training home exercise programme for adults with haemophilia: a pilot study
Haemophilia, 10/09/09
Relevance Score: 85%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Particulate Air Pollution and Cardiovascular Risk: Short-term and Long-term Effects
Seminars in Thrombosis and Hemostasis, 12/15/09
Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis
Seminars in Thrombosis and Hemostasis, 12/15/09
The Bidirectional Relationship of Cancer and Hemostasis and the Potential Role of Anticoagulant Therapy in Moderating Thrombosis and Cancer Spread
Seminars in Thrombosis and Hemostasis, 12/15/09